958P Phase I/II study of 7MW3711, a novel B7-H3-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumorsXinmei Liang, Penghao Wang, Yunchao Huang et al.|Annals of Oncology|2025Cited by 0